Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of intravenous iron on hypoxic pulmonary responses in COPD
2012-002952-17Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose in chronic obstructive pulmonary disease (COPD), sponsored by University of Oxford. Primary endpoint: Arterial oxygen saturation at one week. Started Oct 2012; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-002952-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002952-17.